Kareen L K Coulombe

Title: The Innovative Contributions of Kareen L K Coulombe

Introduction

Kareen L K Coulombe is a notable inventor based in Pawtucket, RI (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative models and systems for evaluating cardiotoxicity and promoting vascularization in ischemic tissues. With a total of 3 patents, his work has the potential to impact both pharmaceutical testing and regenerative medicine.

Latest Patents

One of his latest inventions is the "Human in vitro cardiotoxicity model - The Cardio-Tox Tissue Engineered Model (TEEM)." This invention provides a robust in vitro model for cardiotoxicity evaluation using three-dimensional (3D) human heart microtissues. It quantifies dose-dependent changes in electromechanical activity, resulting in a comprehensive cardiotoxicity and arrhythmia risk assessment of test compounds. Additionally, this invention offers a predictive in vitro screening platform for pro-arrhythmic toxicity testing using human three-dimensional cardiac microtissues. It enables the screening of environmental and pharmaceutical compounds, chemicals, and toxicants to establish safe human exposure levels.

Another significant patent is the "Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue." This invention provides a highly versatile system to promote vascularization in ischemic tissue. The system consists of a fully defined, customizable hydrogel loaded with a potent cocktail of proangiogenic growth factors. The hydrogel's mechanical, degradation, and factor release behavior can be tailored to the specifications of any given target tissue or ischemic disease state. The growth factor cocktail can be optimized for maximal vessel density or size to meet the perfusion specifications required by the tissue.

Career Highlights

Kareen has worked with prestigious institutions such as Brown University and Rhode Island Hospital. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Stephanie Roser and Alicia Minor. Their collaborative efforts have further advanced the research and development of innovative biomedical solutions.

Conclusion

Kareen L K Coulombe's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to advancing healthcare technologies. His work in cardiotoxicity evaluation and tissue revascularization demonstrates the potential for innovation to improve patient outcomes